▪ Introduction
STAN-MED 50 by Pharma Nevis contains 50 mg of Stanozolol per tablet, a higher-strength oral formulation designed for use within regulated medical environments where a licensed healthcare provider determines its necessity. Clinically, Stanozolol has been employed under prescription in the management of hereditary angioedema and select catabolic health conditions where anabolic support may assist treatment outcomes.
Manufactured in accordance with Good Manufacturing Practice (GMP) standards, STAN-MED 50 ensures consistent potency, stability, and pharmaceutical-grade purity. It is intended exclusively for use under medical supervision.
▪ Product Details
-
Active Ingredient: Stanozolol
-
Dosage Strength: 50 mg per tablet
-
Form: Oral tablet
-
Brand: Pharma Nevis
-
Package Size: 60-tablet container
-
Intended Use: Prescription-only medication for approved or clinically justified therapeutic applications
▪ Pharmacokinetics
Stanozolol demonstrates predictable oral absorption and pharmacokinetics:
-
Absorption: Rapid intestinal uptake
-
Half-Life: Approximately 9 hours (varies among individuals)
-
Elimination: Primarily urinary after hepatic metabolism
Clinical monitoring requirements vary depending on patient profile and concurrent therapies.
▪ Usage Recommendations
Use of STAN-MED 50 is restricted to licensed healthcare professionals who determine:
-
Whether Stanozolol is appropriate
-
Correct dosing and duration
-
Necessary monitoring (e.g., hepatic function, lipid levels, hematologic parameters)
Use outside medical oversight or for performance enhancement is inappropriate and associated with serious health risks.
▪ Disclaimer
STAN-MED 50 is intended only for supervised prescription use within legal and clinical guidelines.
Not suitable for:
-
Individuals under 18
-
Pregnant or breastfeeding individuals
-
Patients with contraindications established by a healthcare provider
Not intended for bodybuilding, athletic enhancement, or any non-medical purpose.
